We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cocaine Effects in Humans: Physiology and Behavior - 1

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00000200
First Posted: September 21, 1999
Last Update Posted: January 12, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Columbia University
Information provided by:
National Institute on Drug Abuse (NIDA)
September 20, 1999
September 21, 1999
January 12, 2017
January 1997
January 1998   (Final data collection date for primary outcome measure)
  • Interaction of cocaine and meds on cardio [ Time Frame: 3 hr ]
  • Interaction of cocaine & meds on coc's subjective [ Time Frame: 3 hr ]
  • Effects of medication on cocaine craving [ Time Frame: 3 hr ]
  • Interaction of cocaine and meds on cardio
  • Interaction of cocaine & meds on coc's subjective
  • Effects of medication on cocaine craving
Complete list of historical versions of study NCT00000200 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Cocaine Effects in Humans: Physiology and Behavior - 1
Cocaine Effects in Humans: Physiology and Behavior
The purpose of this study is to compare the effects of buprenorphine or methadone maintenance on cocaine taking and on the physiological and subjective effects of cocaine, including cocaine craving, in opiate-dependent cocaine users.
Not Provided
Interventional
Phase 2
Intervention Model: Single Group Assignment
Masking: Double (Participant, Care Provider)
Primary Purpose: Treatment
Cocaine-Related Disorders
Drug: Methadone
normal maintenance dose
Not Provided
Foltin RW, Fischman MW. Effects of methadone or buprenorphine maintenance on the subjective and reinforcing effects of intravenous cocaine in humans. J Pharmacol Exp Ther. 1996 Sep;278(3):1153-64.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
19
January 1998
January 1998   (Final data collection date for primary outcome measure)
Please contact site for information.
Sexes Eligible for Study: All
18 Years to 45 Years   (Adult)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00000200
NIDA-03818-1
R01-03818-1
Yes
Not Provided
Not Provided
Not Provided
National Institute on Drug Abuse (NIDA)
Columbia University
Principal Investigator: Marian Fischman, Ph.D. Columbia University
National Institute on Drug Abuse (NIDA)
October 2016

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP